Evidence map›Paper›PMID 20210550›Full record

ReviewFuture microbiology2010

Origin of hepatitis delta virus.

John Taylor, Martin Pelchat

Open access · greenAbstract readReview
In one paragraph

Review in Future microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Viroids and the Origin of Life.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodentProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Origins and Evolution of Hepatitis B Virus and Hepatitis D Virus.Cold Spring Harbor perspectives in medicine · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

John TaylorFox Chase Cancer Center, PA 19111, USA. john.taylor@fccc.edu
Martin Pelchat
Fox Chase Cancer Center · USUniversity of Ottawa · CA

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
STRUCTURE AND REPLICATION OF HEPATITIS DELTA VIRUSR01AI026522 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI TAYLOR, JOHN MARSTON · 1988 to 2009
$5.1M
NCI NIH HHS CA-06927NCI NIH HHS P30 CA006927NIAID NIH HHS AI-256522NIAID NIH HHS R01 AI026522
6 · The paper itself

Abstract

This article addresses some of the questions relating to how hepatitis delta virus (HDV), an agent so far unique in the animal world, might have arisen. HDV was discovered in patients infected with hepatitis B virus (HBV). It generally makes HBV infections more damaging to the liver. It is a subviral satellite agent that depends upon HBV envelope proteins for its assembly and ability to infect new cells. In other aspects of replication, HDV is both independent of and very different from HBV. In addition, the small single-stranded circular RNA genome of HDV, and its mechanism of replication, demonstrate an increasing number of similarities to the viroids - a large family of helper-independent subviral agents that cause pathogenesis in plants.

Indexed as

Hepatitis BHepatitis DHepatitis Delta VirusHumans

Identifiers

PMID20210550
PMCPMC2852136
OpenAlexW2106723121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.